Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huahe Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company based in Linhai, China, specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 2002, the company has built a reputation for high-quality production, maintaining compliance with international standards such as US FDA, EU GMP, and EDQM. Its core therapeutic focus includes cardiovascular health, anti-infectives, and gastrointestinal disorders, with a product portfolio featuring widely used medications like amlodipine and valsartan. Huahe Pharmaceutical operates as a key supplier in the global generic drug market and offers contract development and manufacturing (CDMO) services to international partners. The company's facilities are located within the Zhejiang Provincial Chemical and Medical Raw Materials Industrial Zone, supporting large-scale chemical synthesis and formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huahe Pharmaceutical.